Citation: Rt. Penson et Af. Fuller, Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva, J CL ONCOL, 19(8), 2001, pp. 2364-2365
Citation: Rt. Penson et Af. Fuller, Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva, J CL ONCOL, 19(10), 2001, pp. 2767-2768
Authors:
Seiden, MV
Spitzer, TR
McAfee, S
Fuller, AF
Citation: Mv. Seiden et al., Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 412-414
Authors:
Penson, RT
Supko, JG
Seiden, MV
Fuller, AF
Berkowitz, RS
Goodman, A
Campos, SM
MacNeill, KM
Cook, S
Matulonis, UA
Citation: Rt. Penson et al., A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Mullerian tumors, CANCER, 92(5), 2001, pp. 1156-1167
Authors:
Penson, RT
Kronish, K
Duan, Z
Feller, AJ
Stark, P
Cook, SE
Duska, LR
Fuller, AF
Goodman, AK
Nikrui, N
MacNeill, KM
Matulonis, UA
Preffer, FI
Seiden, MV
Citation: Rt. Penson et al., Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel, INT J GYN C, 10(1), 2000, pp. 33-41
Authors:
del Carmen, MG
McIntyre, JF
Fuller, AF
Nikrui, N
Goodman, A
Citation: Mg. Del Carmen et al., Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: A review of fifteen cases, GYNECOL ONC, 79(3), 2000, pp. 457-462
Authors:
Houck, K
Nikrui, N
Duska, L
Chang, YC
Fuller, AF
Bell, D
Goodman, A
Citation: K. Houck et al., Borderline tumors of the ovary: Correlation of frozen and permanent histopathologic diagnosis, OBSTET GYN, 95(6), 2000, pp. 839-843
Authors:
Duska, LR
Penson, R
Supko, JG
Finkelstein, DM
Makastorsis, T
Gallagher, J
Borden, K
Goodman, A
Fuller, AF
Nikrui, N
Seiden, MV
Citation: Lr. Duska et al., A phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer, CLIN CANC R, 5(6), 1999, pp. 1299-1305
Authors:
Masiakos, PT
MacLaughlin, DT
Maheswaran, S
Teixeira, J
Fuller, AF
Shah, PC
Kehas, DJ
Kenneally, MK
Dombkowski, DM
Ha, TU
Preffer, FI
Donahoe, PK
Citation: Pt. Masiakos et al., Human ovarian cancer, cell lines, and primary ascites cells express the human mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS, CLIN CANC R, 5(11), 1999, pp. 3488-3499
Authors:
Lane, AH
Lee, MM
Fuller, AF
Kehas, DJ
Donahoe, PK
MacLaughlin, DT
Citation: Ah. Lane et al., Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors, GYNECOL ONC, 73(1), 1999, pp. 51-55